CNS Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

CNS Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.20 million for the year ending 2025.

  • CNS Pharmaceuticals, Inc. showed an increase of +11.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from CNS Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), CNS Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,446.9%.
  • Historical annual values: Fiscal year 2025: $7.20 million | Fiscal year 2024: $6.46 million | Fiscal year 2023: $548.7 thousand | Fiscal year 2022: $10.06 million | Fiscal year 2021: $5.00 million | Fiscal year 2020: $14.04 million | Fiscal year 2019: $7.24 million | Fiscal year 2018: $282.7 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: